ArticleAnnals of the rheumatic diseases2019

Response to: 'Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis' by Lee and Song.

Yoshikazu NakaokaPubMed ↗Publisher ↗

No numbers read from the abstract.